{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T23:21:35Z","timestamp":1747696895003,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T00:00:00Z","timestamp":1663027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T00:00:00Z","timestamp":1663027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s10067-022-06367-w","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T04:02:36Z","timestamp":1663041756000},"page":"871-877","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Serum-soluble ST2 and systemic sclerosis arthropathy"],"prefix":"10.1007","volume":"42","author":[{"given":"Amalia","family":"Colalillo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Pellicano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7417-8093","authenticated-orcid":false,"given":"Edoardo","family":"Rosato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,13]]},"reference":[{"key":"6367_CR1","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1093\/rheumatology\/kes041","volume":"51","author":"J Avouac","year":"2012","unstructured":"Avouac J, Clements PJ, Khanna D, Furst DE, Allanore Y (2012) Articular involvement in systemic sclerosis. Rheumatology (Oxford) 51:1347\u20131356. https:\/\/doi.org\/10.1093\/rheumatology\/kes041","journal-title":"Rheumatology (Oxford)"},{"key":"6367_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.semarthrit.2019.11.003","volume":"50","author":"RD Sandler","year":"2020","unstructured":"Sandler RD, Matucci-Cerinic M, Hughes M (2020) Musculoskeletal hand involvement in systemic sclerosis. Semin Arthritis Rheum 50:329\u2013334. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.11.003","journal-title":"Semin Arthritis Rheum"},{"key":"6367_CR3","doi-asserted-by":"publisher","first-page":"3646","DOI":"10.1093\/rheumatology\/keaa827","volume":"60","author":"NM van Leeuwen","year":"2021","unstructured":"van Leeuwen NM, Ciaffi J, Liem SIE, Huizinga TWJ, de Vries-Bouwstra JK (2021) Health-related quality of life in patients with systemic sclerosis: evolution over time and main determinants. Rheumatology (Oxford) 60:3646\u20133655. https:\/\/doi.org\/10.1093\/rheumatology\/keaa827","journal-title":"Rheumatology (Oxford)"},{"key":"6367_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1136\/annrheumdis-2014-205295","volume":"75","author":"J Avouac","year":"2016","unstructured":"Avouac J, Walker UA, Hachulla E et al (2016) Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study. Ann Rheum Dis 75:103\u2013109. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205295","journal-title":"Ann Rheum Dis"},{"key":"6367_CR5","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1136\/annrheumdis-2014-205226","volume":"74","author":"B Maurer","year":"2015","unstructured":"Maurer B, Graf N, Michel BA et al (2015) Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database. Ann Rheum Dis 74:1124\u20131131. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205226","journal-title":"Ann Rheum Dis"},{"key":"6367_CR6","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1136\/annrheumdis-2018-213201","volume":"77","author":"W Wu","year":"2018","unstructured":"Wu W, Jordan S, Becker MO et al (2018) Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model. Ann Rheum Dis 77:1326\u20131332. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213201","journal-title":"Ann Rheum Dis"},{"key":"6367_CR7","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1093\/rheumatology\/kew246","volume":"55","author":"V L\u00f3r\u00e1nd","year":"2016","unstructured":"L\u00f3r\u00e1nd V, B\u00e1lint Z, Komj\u00e1ti D et al (2016) Validation of disease activity indices using the 28 joint counts in systemic sclerosis. Rheumatology (Oxford) 55:1849\u20131858. https:\/\/doi.org\/10.1093\/rheumatology\/kew246","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 131","key":"6367_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.55563\/clinexprheumatol\/cl3bbb","volume":"39","author":"V L\u00f3r\u00e1nd","year":"2021","unstructured":"L\u00f3r\u00e1nd V, Nagy G, B\u00e1lint Z et al (2021) Sensitivity to change of joint count composite indices in 72 patients with systemic sclerosis. Clin Exp Rheumatol 39(Suppl 131):77\u201384. https:\/\/doi.org\/10.55563\/clinexprheumatol\/cl3bbb","journal-title":"Clin Exp Rheumatol"},{"key":"6367_CR9","first-page":"S28","volume":"28","author":"KS Torok","year":"2010","unstructured":"Torok KS, Baker NA, Lucas M, Domsic RT, Boudreau R, Medsger TA Jr (2010) Reliability and validity of the delta finger-to-palm (FTP), a new measure of finger range of motion in systemic sclerosis. Clin Exp Rheumatol 28:S28\u2013S36","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl 119","key":"6367_CR10","first-page":"141","volume":"37","author":"D Xu","year":"2019","unstructured":"Xu D, Barbour M, Jiang HR, Mu R (2019) Role of IL-33\/ST2 signaling pathway in systemic sclerosis and other fibrotic diseases. Clin Exp Rheumatol 37(Suppl 119):141\u2013146","journal-title":"Clin Exp Rheumatol"},{"key":"6367_CR11","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.3389\/fimmu.2018.02432","volume":"9","author":"OS Kotsiou","year":"2018","unstructured":"Kotsiou OS, Gourgoulianis KI, Zarogiannis SG (2018) IL-33\/ST2 Axis in Organ Fibrosis. Front Immunol 9:2432. https:\/\/doi.org\/10.3389\/fimmu.2018.02432","journal-title":"Front Immunol"},{"key":"6367_CR12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.cytogfr.2019.04.004","volume":"50","author":"X Liu","year":"2019","unstructured":"Liu X, Xiao Y, Pan Y, Li H, Zheng SG, Su W (2019) The role of the IL-33\/ST2 axis in autoimmune disorders: Friend or foe? Cytokine Growth Factor Rev 50:60\u201374. https:\/\/doi.org\/10.1016\/j.cytogfr.2019.04.004","journal-title":"Cytokine Growth Factor Rev"},{"key":"6367_CR13","doi-asserted-by":"publisher","first-page":"825567","DOI":"10.3389\/fmed.2022.825567","volume":"9","author":"AG Versace","year":"2022","unstructured":"Versace AG, Bitto A, Ioppolo C et al (2022) IL-13 and IL-33 Serum Levels Are Increased in Systemic Sclerosis Patients With Interstitial Lung Disease. Front Med (Lausanne) 9:825567. https:\/\/doi.org\/10.3389\/fmed.2022.825567","journal-title":"Front Med (Lausanne)"},{"key":"6367_CR14","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.3389\/fimmu.2018.02663","volume":"9","author":"L Li","year":"2018","unstructured":"Li L, Zhu H, Zuo X (2018) Interleukin-33 in Systemic Sclerosis: Expression and Pathogenesis. Front Immunol 9:2663. https:\/\/doi.org\/10.3389\/fimmu.2018.02663","journal-title":"Front Immunol"},{"key":"6367_CR15","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3389\/fimmu.2019.02025","volume":"10","author":"D Xu","year":"2019","unstructured":"Xu D, Mu R, Wei X (2019) The Roles of IL-1 Family Cytokines in the Pathogenesis of Systemic Sclerosis. Front Immunol 10:2025. https:\/\/doi.org\/10.3389\/fimmu.2019.02025","journal-title":"Front Immunol"},{"key":"6367_CR16","doi-asserted-by":"publisher","first-page":"316","DOI":"10.4103\/0366-6999.223847","volume":"131","author":"LJ Shi","year":"2018","unstructured":"Shi LJ, Liu C, Li JH, Zhu XY, Li YN, Li JT (2018) Elevated Levels of Soluble ST2 were Associated with Rheumatoid Arthritis Disease Activity and Ameliorated Inflammation in Synovial Fibroblasts. Chin Med J (Engl) 131:316\u2013322. https:\/\/doi.org\/10.4103\/0366-6999.223847","journal-title":"Chin Med J (Engl)"},{"key":"6367_CR17","doi-asserted-by":"publisher","first-page":"848","DOI":"10.2310\/jim.0b013e31828deed2","volume":"61","author":"XL Li","year":"2013","unstructured":"Li XL, Lin TT, Qi CY et al (2013) Elevated serum level of IL-33 and sST2 in patients with ankylosing spondylitis: associated with disease activity and vascular endothelial growth factor. J Investig Med 61:848\u2013851. https:\/\/doi.org\/10.2310\/jim.0b013e31828deed2","journal-title":"J Investig Med"},{"key":"6367_CR18","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.cyto.2013.03.007","volume":"62","author":"S Ishikawa","year":"2013","unstructured":"Ishikawa S, Shimizu M, Ueno K, Sugimoto N, Yachie A (2013) Soluble ST2 as a marker of disease activity in systemic juvenile idiopathic arthritis. Cytokine 62:272\u2013277. https:\/\/doi.org\/10.1016\/j.cyto.2013.03.007","journal-title":"Cytokine"},{"key":"6367_CR19","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis 72:1747\u20131755. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204424","journal-title":"Ann Rheum Dis"},{"key":"6367_CR20","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202\u2013205","journal-title":"J Rheumatol"},{"key":"6367_CR21","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1136\/annrheumdis-2016-209768","volume":"76","author":"G Valentini","year":"2017","unstructured":"Valentini G, Iudici M, Walker UA et al (2017) The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index. Ann Rheum Dis 76:270\u2013276. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209768","journal-title":"Ann Rheum Dis"},{"key":"6367_CR22","first-page":"S42","volume":"21","author":"TA Medsger Jr","year":"2003","unstructured":"Medsger TA Jr, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W (2003) Assessment of disease severity and prognosis. Clin Exp Rheumatol 21:S42\u2013S46","journal-title":"Clin Exp Rheumatol"},{"key":"6367_CR23","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1002\/1529-0131(199706)40:6%3C1146::aid-art19%3E3.0.co;2-9","volume":"40","author":"VD Steen","year":"1997","unstructured":"Steen VD, Medsger TA Jr (1997) The palpable tendon friction rub: an important physical examination finding in patients with systemic sclerosis. Arthritis Rheum 40:1146\u20131151. https:\/\/doi.org\/10.1002\/1529-0131(199706)40:6%3C1146::aid-art19%3E3.0.co;2-9","journal-title":"Arthritis Rheum"},{"key":"6367_CR24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van\u2019t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44\u201348. https:\/\/doi.org\/10.1002\/art.1780380107","journal-title":"Arthritis Rheum"},{"key":"6367_CR25","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.3346\/jkms.2011.26.9.1132","volume":"26","author":"YS Hong","year":"2011","unstructured":"Hong YS, Moon SJ, Joo YB et al (2011) Measurement of interleukin-33 (IL-33) and IL-33 receptors (sST2 and ST2L) in patients with rheumatoid arthritis. J Korean Med Sci 26:1132\u20131139. https:\/\/doi.org\/10.3346\/jkms.2011.26.9.1132","journal-title":"J Korean Med Sci"},{"key":"6367_CR26","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/rheumatology\/kep402","volume":"49","author":"MY Mok","year":"2010","unstructured":"Mok MY, Huang FP, Ip WK et al (2010) Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus. Rheumatology (Oxford) 49:520\u2013527. https:\/\/doi.org\/10.1093\/rheumatology\/kep402","journal-title":"Rheumatology (Oxford)"},{"key":"6367_CR27","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/acr.21668","volume":"64","author":"M Elhai","year":"2012","unstructured":"Elhai M, Guerini H, Bazeli R et al (2012) Ultrasonographic hand features in systemic sclerosis and correlates with clinical, biologic, and radiographic findings. Arthritis Care Res (Hoboken) 64:1244\u20131249. https:\/\/doi.org\/10.1002\/acr.21668","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"6367_CR28","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.3899\/jrheum.091165","volume":"37","author":"J Avouac","year":"2010","unstructured":"Avouac J, Walker U, Tyndall A et al (2010) Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol 37:1488\u20131501. https:\/\/doi.org\/10.3899\/jrheum.091165","journal-title":"J Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06367-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06367-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06367-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T09:05:30Z","timestamp":1676538330000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06367-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,13]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["6367"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06367-w","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2022,9,13]]},"assertion":[{"value":"24 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests and funding"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}